Dr. Giaccia is the Co-Founder, Senior Scientific Strategist, and Chairman of AKSO Biopharmaceutical, Inc. He currently serves as the Director of the Oxford Institute of Radiation Oncology in the UK and holds the title of Jack, Lulu, and Sam Wilson Professor Emeritus of Radiation Oncology at Stanford University School of Medicine. During his tenure at Stanford, Dr. Giaccia held several key leadership positions, including Director of the Division of Radiation and Cancer Biology, Associate Director of the Comprehensive Cancer Center, and Director of the Cancer Biology Graduate Program. He is internationally recognized for his pioneering work in the tumor microenvironment, hypoxia, and HIF-1-mediated pathways in cancer. As a founding member of AKSO Bio, Dr. Giaccia brings extensive expertise in biotech entrepreneurship and commercialization. Among his many accolades, he has received the ASTRO Gold Medal and the National Cancer Institute Outstanding Investigator Award, and he has been elected to the National Academy of Medicine. Dr. Giaccia has co-authored over 260 publications in peer-reviewed journals and is the inventor of numerous patents.